Cagrilintide

Synonyms: Cagrilintide, 1415456-99-3, Amylin analog, Long-acting amylin analog, NN-9935, Cagrilintide acetate

Cagrilintide is a synthetic analog of human amylin, a peptide hormone that works alongside insulin to regulate postprandial glucose levels and signal satiety. Developed by Novo Nordisk, this long-acting amylin analog is designed for once-weekly dosing, making it a promising candidate for obesity and type 2 diabetes management. Its extended half-life is achieved through fatty acid acylation, which promotes albumin binding and slows renal clearance.

Funzione

• Amylin receptor agonist: Activates amylin receptors, reducing food intake and delaying gastric emptying.
• Regolazione dell'appetito: Enhances satiety signaling, leading to reduced caloric intake.
• Controllo del peso: Promotes weight loss in overweight and obese individuals.
• Glycemic control: Helps regulate postprandial glucose levels.

Fonte e standardizzazione

• Fonte: Synthetic peptide, produced via solid-phase peptide synthesis.
• Standardizzazione: Purity ≥98% (HPLC), peptide content 70-90%.
• Moduli: Lyophilized powder, acetate salt.
• Applicazioni: Research on obesity, type 2 diabetes, and metabolic disorders.

Documentazione e forniture

• MOQ: 5g
• Capacità mensile: 1 kg
• Tempi di consegna: 5-10 days after order
• Documentazione: COA, SDS, TDS
• Imballaggio: Sealed vials or custom packaging

Richiesta di preventivo

• Il nostro indirizzo: 280 Main Street, Xian, Shaanxi, Cina
• LyvBio S.r.l. — E-mail: info@lyvbio.com